Jazmina L. Cruz-Gonzalez

Brisbane, QLD 4102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia.

IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia.

Journal: Tumour virus research

Published: January 14, 2026

Immunomodulation of UVB-induced regulatory T cells prevents the establishment of squamous cell carcinoma.

Immunomodulation of UVB-induced regulatory T cells prevents the establishment of squamous cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: November 14, 2025

Intra- and inter-organ communications in aging and cancer: Local and global spatial perspectives.

Intra- and inter-organ communications in aging and cancer: Local and global spatial perspectives.

Journal: Seminars in cell & developmental biology

Published: October 29, 2025

Community Co-Design of a Quick Guide to Inform Digital Health Promotion Strategies for Asymptomatic Women at Risk of Chronic Disease.

Community Co-Design of a Quick Guide to Inform Digital Health Promotion Strategies for Asymptomatic Women at Risk of Chronic Disease.

Journal: Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals

Published: October 08, 2025

Spatial transcriptomics and histopathological analyses reveal potential biomarkers and immune features linked to recurrence in head and neck cancer.

Spatial transcriptomics and histopathological analyses reveal potential biomarkers and immune features linked to recurrence in head and neck cancer.

Journal: Frontiers in immunology

Published: September 26, 2025

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Journal: British journal of cancer

Published: July 24, 2025

Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study.

Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2025

Harnessing cytokine immunocomplexes and cytokine fusion proteins for cancer Therapy: Mechanisms and clinical potential.

Harnessing cytokine immunocomplexes and cytokine fusion proteins for cancer Therapy: Mechanisms and clinical potential.

Journal: Cancer treatment reviews

Published: February 24, 2025

A synthetic cyclic peptide for promoting antigen presentation and immune activation.

A synthetic cyclic peptide for promoting antigen presentation and immune activation.

Journal: NPJ vaccines

Published: July 24, 2024

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Journal: Journal for immunotherapy of cancer

Published: January 11, 2024

Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure.

Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure.

Journal: NPJ precision oncology

Published: March 03, 2023

Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.

Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.

Journal: Pharmaceutics

Published: January 12, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026